IRIS
CASTAGNA, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.292
NA - Nord America 8.006
AS - Asia 4.042
SA - Sud America 851
AF - Africa 288
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.507
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.875
RU - Federazione Russa 1.969
IT - Italia 1.611
GB - Regno Unito 1.417
SG - Singapore 1.395
IE - Irlanda 1.133
CN - Cina 1.103
BR - Brasile 690
SE - Svezia 504
VN - Vietnam 489
FR - Francia 409
DE - Germania 340
HK - Hong Kong 340
UA - Ucraina 261
FI - Finlandia 230
KR - Corea 187
IN - India 171
ZA - Sudafrica 166
NL - Olanda 99
ES - Italia 87
CA - Canada 68
AR - Argentina 60
TR - Turchia 58
PL - Polonia 57
BD - Bangladesh 44
JP - Giappone 43
CI - Costa d'Avorio 33
IQ - Iraq 33
MX - Messico 31
AT - Austria 27
EC - Ecuador 27
MA - Marocco 27
BE - Belgio 26
AU - Australia 23
IR - Iran 23
CZ - Repubblica Ceca 21
CL - Cile 19
UZ - Uzbekistan 17
ID - Indonesia 16
VE - Venezuela 15
EG - Egitto 13
KE - Kenya 13
NG - Nigeria 13
PK - Pakistan 13
CO - Colombia 12
JO - Giordania 12
LT - Lituania 12
PY - Paraguay 11
RO - Romania 11
SA - Arabia Saudita 11
CH - Svizzera 10
JM - Giamaica 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
DZ - Algeria 8
GR - Grecia 8
NP - Nepal 8
IL - Israele 7
PH - Filippine 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
ET - Etiopia 6
KG - Kirghizistan 6
MY - Malesia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
LU - Lussemburgo 5
PA - Panama 5
BB - Barbados 4
CR - Costa Rica 4
EU - Europa 4
KZ - Kazakistan 4
LB - Libano 4
MK - Macedonia 4
OM - Oman 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
AM - Armenia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
PE - Perù 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
GY - Guiana 2
IM - Isola di Man 2
IS - Islanda 2
NI - Nicaragua 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
Totale 21.489
Salva come PNG Salva come JPEG
Città #
Southend 1.239
Dublin 1.109
Dallas 993
Fairfield 749
Singapore 705
Ashburn 577
Moscow 558
Santa Clara 482
Chandler 420
San Jose 342
Woodbridge 332
Hong Kong 324
Wilmington 290
Houston 276
Hefei 272
Seattle 262
Cambridge 255
Beijing 244
Siena 232
Florence 223
Ann Arbor 217
The Dalles 184
Seoul 180
Jacksonville 177
Los Angeles 164
Ho Chi Minh City 162
Johannesburg 152
Lauterbourg 143
Princeton 143
Munich 130
Helsinki 128
Milan 124
New York 118
Council Bluffs 109
Hanoi 109
Rome 71
São Paulo 71
San Mateo 67
Shanghai 60
Buffalo 55
Orem 51
Nanjing 50
Turku 44
Chicago 43
Bengaluru 42
Redondo Beach 42
San Diego 40
Chennai 39
Lappeenranta 38
Boardman 37
Málaga 37
London 36
Tokyo 35
Warsaw 35
Abidjan 33
Naples 31
Dearborn 30
Montreal 30
Saint Petersburg 29
Stockholm 28
Düsseldorf 27
Brooklyn 26
Portsmouth 26
Brussels 24
Frankfurt am Main 24
Bologna 23
Amsterdam 22
Da Nang 22
Haiphong 21
Columbus 18
Rio de Janeiro 18
Atlanta 17
Manchester 17
Redwood City 17
Ankara 16
Guangzhou 16
Nuremberg 16
Phoenix 16
Prato 16
Belo Horizonte 15
Tashkent 15
Toronto 15
Vienna 15
Boston 14
Denver 14
Mumbai 14
San Francisco 14
Baghdad 13
Bari 13
Fremont 13
Izmir 13
Tianjin 13
Turin 13
Abuja 12
Biên Hòa 12
Brasília 12
Curitiba 12
Jiaxing 12
Norwalk 12
Poplar 12
Totale 13.858
Salva come PNG Salva come JPEG
Nome #
CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI 434
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 369
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 312
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 311
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 304
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 299
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 297
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 293
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 291
Approach to and treatment of differentiated thyroid carcinoma 284
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 283
Acute exogenous TSH administration stimulates leptin secretion in vivo 271
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 270
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 263
Reference range of serum calcitonin in pediatric population 262
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 261
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 259
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 258
Clinical significance of type 2 iodothyronine deiodinase polymorphism 255
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 248
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 242
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 238
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 237
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 233
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 218
Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case–control study in an Italian cohort 218
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 217
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 215
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 213
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC 212
Medullary thyroid carcinoma 211
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 209
SEX HORMONES IN LONG QT SYNDROME AND TORSADES DE POINTES (TDP) 200
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 199
BROX haploinsufficiency in familial nonmedullary thyroid cancer 199
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 199
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 197
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 197
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 194
Monitoraggio del nodulo tiroideo benigno in accordo con la classe di rischio ecografica 192
Controlling Nutritional Status (CONUT) Score and Micronutrient Deficiency in Bariatric Patients: Midterm Outcomes of Roux-en-Y Gastric Bypass Versus One Anastomosis Gastric Bypass/Mini Gastric Bypass 192
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 191
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 189
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 187
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 184
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 183
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 182
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 180
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 179
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy 179
Assessing the Prevalence of Male Obesity-Associated Gonadal Dysfunction in Severe Obesity: A Focus on the Impact of Bariatric Surgery and Surgical Approaches 178
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 177
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 175
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 175
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 171
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 171
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 170
Il carcinoma familiare non midollare della tiroide non sindromico 169
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 167
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 165
New specific skeletal muscle mass index cut-offs for the assessment of sarcopenia in patients with severe obesity 164
Tireotossicosi in gravidanza e nel post-partum 163
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in low and Intermediate DTC Patients 162
Silent thyroiditis following vaccination against COVID-19: report of two cases 161
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 161
Radioiodine therapy in the different stages of differentiated thyroid cancer 160
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 159
New insight in the follow-up strategies of differentiated thyroid cancer 158
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. 157
Familial non-medullary thyroid cancer: a critical review 156
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer 155
Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight 153
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer 152
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 152
Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors 149
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 149
Improvement of overall survival using TKIs as salvage therapy in advanced thyroid carcinoma: Real‐life data on a single center experience 147
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: A possible novel iodine deficiency disorder in developed countries 144
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 143
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 142
Nodular Thyroid Disease in the Era of Precision Medicine 141
Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study 141
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 140
Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity 138
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer 137
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels 136
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 135
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 134
Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery 134
Associazione Americana di Endocrinologia Clinica e Associazione Medici Endocrinologi: algoritmo per la diagnostica dei noduli tiroidei 131
Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy 129
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma 127
null 126
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 121
A case of papillary thyroid cancer without aggressive histological features with nodal metastyases in an older patients 120
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 120
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value 119
In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males” 113
Carcinoma midollare della tiroidea trattato con vandetanib: fattori predittivi di risposta duratura 113
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up 113
Totale 19.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021488 0 0 0 0 0 0 0 0 0 262 115 111
2021/20221.358 120 110 110 141 78 85 38 51 80 149 167 229
2022/20231.787 109 218 219 200 132 365 78 123 168 68 54 53
2023/20241.979 67 48 161 123 138 407 666 78 43 39 44 165
2024/20254.124 93 183 476 273 468 302 161 206 458 210 403 891
2025/20268.041 700 1.108 861 1.197 1.622 328 1.135 365 298 427 0 0
Totale 21.916